NEW YORK (GenomeWeb News) – Danaher Motion – Dover, a branch of US technology conglomerate Danaher that has been developing a low-cost open-source next-generation sequencer with George Church’s group at Harvard Medical School, is scheduled to ship the first commercial version of the tool later this week to the Church lab, GenomeWeb Daily News sister publication In Sequence reported yesterday.
In addition, the Broad Institute said it will order at least one of the instruments in order to evaluate the technology, according to the company.
Danaher has already received other orders and order commitments for the instrument, including an order from the Max Planck Institute of Molecular Genetics in Berlin, and plans to showcase the instrument in a hotel suite at the Advances in Genome Biology and Technology meeting on Marco Island this week.
The company said it will market the instrument, called the Polonator G.007, with reagent kits, flow cells, user support, and protocols and software developed by the Church lab.
The system currently supports paired-end sequencing with read lengths of two times 14 bases. Performance metrics such as accuracy and throughput will be available within a month, according to the Church lab.
According to marketing literature, the Danaher-Church team has “identified the upfront and recurring cost of second-generation sequencing as key factors inhibiting the rate of adoption, and have assiduously sought to drive these as low as possible.”
The instrument’s list price, $150,000, is indeed lower than those of other available next-generation sequencers — sold by Applied Biosystems, Illumina, and Roche’s 454 Life Sciences subsidiary — which list for between $430,000 and almost $600,000.
Researchers in the Church lab are still determining the performance of the instrument, including its throughput and accuracy, and “expect those figures within the next month,” Greg Porreca, a developer in the Church group, told In Sequence by e-mail this week.
A comprehensive version of this article appears in this week's issue of In Sequence.